Message from Chairman

Inter Pharma Public Company Limited (“the Company”) recognizes its responsibility for sustainability and business growth. The Company places great emphasis on environmental stewardship, social responsibility, and good corporate governance, ensuring their continuous integration into its business operations. This commitment is demonstrated through the research and development of comprehensive healthcare products for humans and animals, as well as the continuous expansion of investments in businesses related to its core operations.

The Company’s management approach is guided by three key principles:

  1. Becoming an Innovation-Driven Organization
  2. Corporate Governance, Risk Management, and Compliance
  3. Creating Long-Term Value for Stakeholders

The Company firmly believes that by adhering to good corporate governance practices, maintaining a strong commitment to social and environmental responsibility, and continuously striving for improvement, it can achieve sustainable business growth.

In 2024, the Company acknowledged the critical challenges posed by environmental issues and greenhouse gas emissions. To address these concerns, it has implemented a solar rooftop power generation system with a total capacity of 851.20 kWp at its Ayutthaya factory. This initiative aims to reduce greenhouse gas emissions and decrease electricity consumption from the Provincial Electricity Authority.

Furthermore, the Company has expanded its investments by acquiring a stake in Inter Pharma Medtech Co., Ltd., a company specializing in the distribution of medical devices and equipment, as well as providing rehabilitation and physical therapy services. This investment is part of the Company's strategic expansion, reinforcing its position as a leader in the comprehensive healthcare industry, in alignment with its corporate goals and strategies.

On behalf of the Board of Directors, management team, and employees, the Company extends its sincere gratitude to all stakeholders for their continued cooperation, trust, and support. This unwavering support enables the Company to achieve significant milestones and create long-term value for all stakeholders.

Clinical Prof. Emeritus Udom Kanchintom, MD.

Chairman